Feb. 3 at 2:03 PM
Are MedTech stocks bracing for a bumpy Q4 ride? 🚑
The sector's earnings are expected to decline 2.4% despite 8.7% revenue growth, with major players like
$BSX and
$ALGN set to report results tomorrow. AI-driven innovations are expected to support performance, but geopolitical tensions and supply-chain disruptions could weigh heavily.
Find out what's in store for these stocks tomorrow 👉 https://www.zacks.com/stock/news/2827637/medtech-stocks-to-watch-for-earnings-on-feb-4-bsx-algn-more?cid=sm-stocktwits-2-2827637-body-31611&ADID=SYND_STOCKTWITS_TWEET_2_2827637_BODY_31611